Literature DB >> 15816368

Mutational analysis of the inhibin alpha gene in preeclamptic women.

P Ciarmela1, P Florio, S Battistini, D Grasso, T Amato, S Boschi, L Marozio, C Benedetto, F Petraglia.   

Abstract

BACKGROUND: Preeclampsia (PE) is a disorder that occurs in at least 5% of pregnancies and affects both the mother and the unborn baby. A dramatic increase of maternal serum inhibin A concentration in the second and third trimester of pregnancy is a common feature of PE and inhibin A measurement may add significant prognostic information for predicting PE in pregnant women.
DESIGN: We evaluated the presence and prevalence of gene polymorphisms for inhibin alpha subunit (INHalpha) in patients affected by PE (no.=50; study group), and in the general population (control group composed of 103 women and 42 men).
METHODS: DNA extraction, single strand conformation polymorphism analysis, DNA sequencing, restriction fragment length polymorphism analysis, and Fisher's exact test were used.
RESULTS: A 769G-->A transition was found in INHalpha1, but not in INHalpha2 or INHalpha3 fragment. This variant was found in 10/145 normal controls (7,6%), and in 1/50 preeclamptic patients (2%), without significant difference between the two groups (p=0.29).
CONCLUSIONS: The prevalence of INHalpha gene variants is not increased in PE. Due to its frequency, the 769G-->A transition may be considered a polymorphism present in the general Italian population.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15816368     DOI: 10.1007/bf03345526

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  12 in total

Review 1.  Pre-eclampsia.

Authors:  J J Walker
Journal:  Lancet       Date:  2000-10-07       Impact factor: 79.321

2.  Control of the human inhibin alpha chain promoter in cytotrophoblast cells differentiating into syncytium.

Authors:  F Debieve; K Thomas
Journal:  Mol Hum Reprod       Date:  2002-03       Impact factor: 4.025

Review 3.  Predictive value of hormone measurements in maternal and fetal complications of pregnancy.

Authors:  Fernando M Reis; Donato D'Antona; Felice Petraglia
Journal:  Endocr Rev       Date:  2002-04       Impact factor: 19.871

4.  Inhibin: a candidate gene for premature ovarian failure.

Authors:  A N Shelling; K A Burton; A L Chand; C C van Ee; J T France; C M Farquhar; S R Milsom; D R Love; K Gersak; K Aittomäki; I M Winship
Journal:  Hum Reprod       Date:  2000-12       Impact factor: 6.918

5.  A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies.

Authors:  D K Lahiri; J I Nurnberger
Journal:  Nucleic Acids Res       Date:  1991-10-11       Impact factor: 16.971

Review 6.  Chemical and biological characterization of the inhibin family of protein hormones.

Authors:  W Vale; C Rivier; A Hsueh; C Campen; H Meunier; T Bicsak; J Vaughan; A Corrigan; W Bardin; P Sawchenko
Journal:  Recent Prog Horm Res       Date:  1988

Review 7.  Changes in inhibins and activin secretion in healthy and pathological pregnancies.

Authors:  P Florio; L Cobellis; S Luisi; P Ciarmela; F M Severi; C Bocchi; F Petraglia
Journal:  Mol Cell Endocrinol       Date:  2001-06-30       Impact factor: 4.102

8.  Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy.

Authors: 
Journal:  Am J Obstet Gynecol       Date:  2000-07       Impact factor: 8.661

9.  Mutation analysis of the inhibin alpha gene in a cohort of Italian women affected by ovarian failure.

Authors:  Anna Marozzi; C Porta; W Vegetti; P G Crosignani; M G Tibiletti; L Dalprà; E Ginelli
Journal:  Hum Reprod       Date:  2002-07       Impact factor: 6.918

10.  Expression of betaglycan in pregnant tIssues throughout gestation.

Authors:  Pasquapina Ciarmela; Pasquale Florio; Paolo Toti; Daniela Grasso; Rosa Santopietro; Piero Tosi; Felice Petraglia
Journal:  Eur J Endocrinol       Date:  2003-11       Impact factor: 6.664

View more
  2 in total

1.  Heterogeneity-based genome search meta-analysis for preeclampsia.

Authors:  Elias Zintzaras; Georgios Kitsios; Gavan A Harrison; Hannele Laivuori; Katja Kivinen; Juha Kere; Ioannis Messinis; Ioannis Stefanidis; John P A Ioannidis
Journal:  Hum Genet       Date:  2006-07-26       Impact factor: 4.132

2.  The 769G>A variant of the inhibin-alpha gene in Korean patients with preeclampsia.

Authors:  S Y Kim; J-H Lim; J-H Yang; M-Y Kim; M-H Kim; S-Y Park; H-M Ryu
Journal:  J Endocrinol Invest       Date:  2008-08       Impact factor: 4.256

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.